T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154

M. J. Cantwell, W. G. Wierda, Izidore Lossos, R. Levy, T. J. Kipps

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purified, high-titer adenovirus encoding murine CD154 (Ad-CD154) or human CD154 (Ad-hCD154) was used to infect lymph node cells isolated from patients with follicle center lymphoma. Infection of lymphoma B cells with Ad-CD154 at a multiplicity of infection (MOI) ratio of 100 or higher resulted in high-level transgene expression. Additionally, upon infection of lymphoma B cells, only Ad-CD154 resulted in surface expression of CD154, despite similar, high-level expression of either human or mouse CD154 by HeLa cells infected with Ad-hCD154 or Ad-CD154, respectively. Moreover, infection of lymphoma B cells with Ad-CD154, but not Ad-hCD154 or adenovirus encoding Eschericheria coli beta-galactosidase (Ad-LacZ), induced the neoplastic B cells to express higher levels of immune costimulatory molecules that are required for proficient presentation of antigen to T cells. Consistent with this, we found that Ad-CD154 infected lymphoma B cells could stimulate T cells to proliferate or produce interferon-gamma in allogeneic or autologous mixed lymphocyte interactions. We conclude that lymphoma B cells can be infected with Ad-CD154 and that this significantly enhances their recognition by allogeneic or autologous T cells. As such, Ad-CD154-transduced lymphoma B cells may have potential for the active immune therapy of patients with follicle center lymphoma.

Original languageEnglish
Pages (from-to)1451-1457
Number of pages7
JournalLeukemia
Volume15
Issue number9
DOIs
StatePublished - Sep 6 2001
Externally publishedYes

Fingerprint

B-Cell Lymphoma
Adenoviridae
T-Lymphocytes
Infection
Lymphoma
Antigen Presentation
beta-Galactosidase
Transgenes
HeLa Cells
Interferon-gamma
B-Lymphocytes
Lymph Nodes
Lymphocytes

Keywords

  • Adenovirus
  • CD154
  • Follicle center lymphoma

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154. / Cantwell, M. J.; Wierda, W. G.; Lossos, Izidore; Levy, R.; Kipps, T. J.

In: Leukemia, Vol. 15, No. 9, 06.09.2001, p. 1451-1457.

Research output: Contribution to journalArticle

Cantwell, M. J. ; Wierda, W. G. ; Lossos, Izidore ; Levy, R. ; Kipps, T. J. / T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154. In: Leukemia. 2001 ; Vol. 15, No. 9. pp. 1451-1457.
@article{9e0cd7d09aee48e889361d2c9bb32f28,
title = "T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154",
abstract = "Purified, high-titer adenovirus encoding murine CD154 (Ad-CD154) or human CD154 (Ad-hCD154) was used to infect lymph node cells isolated from patients with follicle center lymphoma. Infection of lymphoma B cells with Ad-CD154 at a multiplicity of infection (MOI) ratio of 100 or higher resulted in high-level transgene expression. Additionally, upon infection of lymphoma B cells, only Ad-CD154 resulted in surface expression of CD154, despite similar, high-level expression of either human or mouse CD154 by HeLa cells infected with Ad-hCD154 or Ad-CD154, respectively. Moreover, infection of lymphoma B cells with Ad-CD154, but not Ad-hCD154 or adenovirus encoding Eschericheria coli beta-galactosidase (Ad-LacZ), induced the neoplastic B cells to express higher levels of immune costimulatory molecules that are required for proficient presentation of antigen to T cells. Consistent with this, we found that Ad-CD154 infected lymphoma B cells could stimulate T cells to proliferate or produce interferon-gamma in allogeneic or autologous mixed lymphocyte interactions. We conclude that lymphoma B cells can be infected with Ad-CD154 and that this significantly enhances their recognition by allogeneic or autologous T cells. As such, Ad-CD154-transduced lymphoma B cells may have potential for the active immune therapy of patients with follicle center lymphoma.",
keywords = "Adenovirus, CD154, Follicle center lymphoma",
author = "Cantwell, {M. J.} and Wierda, {W. G.} and Izidore Lossos and R. Levy and Kipps, {T. J.}",
year = "2001",
month = "9",
day = "6",
doi = "10.1038/sj.leu.2402208",
language = "English",
volume = "15",
pages = "1451--1457",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154

AU - Cantwell, M. J.

AU - Wierda, W. G.

AU - Lossos, Izidore

AU - Levy, R.

AU - Kipps, T. J.

PY - 2001/9/6

Y1 - 2001/9/6

N2 - Purified, high-titer adenovirus encoding murine CD154 (Ad-CD154) or human CD154 (Ad-hCD154) was used to infect lymph node cells isolated from patients with follicle center lymphoma. Infection of lymphoma B cells with Ad-CD154 at a multiplicity of infection (MOI) ratio of 100 or higher resulted in high-level transgene expression. Additionally, upon infection of lymphoma B cells, only Ad-CD154 resulted in surface expression of CD154, despite similar, high-level expression of either human or mouse CD154 by HeLa cells infected with Ad-hCD154 or Ad-CD154, respectively. Moreover, infection of lymphoma B cells with Ad-CD154, but not Ad-hCD154 or adenovirus encoding Eschericheria coli beta-galactosidase (Ad-LacZ), induced the neoplastic B cells to express higher levels of immune costimulatory molecules that are required for proficient presentation of antigen to T cells. Consistent with this, we found that Ad-CD154 infected lymphoma B cells could stimulate T cells to proliferate or produce interferon-gamma in allogeneic or autologous mixed lymphocyte interactions. We conclude that lymphoma B cells can be infected with Ad-CD154 and that this significantly enhances their recognition by allogeneic or autologous T cells. As such, Ad-CD154-transduced lymphoma B cells may have potential for the active immune therapy of patients with follicle center lymphoma.

AB - Purified, high-titer adenovirus encoding murine CD154 (Ad-CD154) or human CD154 (Ad-hCD154) was used to infect lymph node cells isolated from patients with follicle center lymphoma. Infection of lymphoma B cells with Ad-CD154 at a multiplicity of infection (MOI) ratio of 100 or higher resulted in high-level transgene expression. Additionally, upon infection of lymphoma B cells, only Ad-CD154 resulted in surface expression of CD154, despite similar, high-level expression of either human or mouse CD154 by HeLa cells infected with Ad-hCD154 or Ad-CD154, respectively. Moreover, infection of lymphoma B cells with Ad-CD154, but not Ad-hCD154 or adenovirus encoding Eschericheria coli beta-galactosidase (Ad-LacZ), induced the neoplastic B cells to express higher levels of immune costimulatory molecules that are required for proficient presentation of antigen to T cells. Consistent with this, we found that Ad-CD154 infected lymphoma B cells could stimulate T cells to proliferate or produce interferon-gamma in allogeneic or autologous mixed lymphocyte interactions. We conclude that lymphoma B cells can be infected with Ad-CD154 and that this significantly enhances their recognition by allogeneic or autologous T cells. As such, Ad-CD154-transduced lymphoma B cells may have potential for the active immune therapy of patients with follicle center lymphoma.

KW - Adenovirus

KW - CD154

KW - Follicle center lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0034845155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034845155&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2402208

DO - 10.1038/sj.leu.2402208

M3 - Article

VL - 15

SP - 1451

EP - 1457

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 9

ER -